Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Changes In Stockholders' Equity

v3.19.1
Consolidated Statements Of Changes In Stockholders' Equity - USD ($)
Preferred Stock
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Other Comprehensive Income / Loss
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2016 3,275,742 8,731,029          
Beginning balance, value at Dec. 31, 2016 $ 3,275 $ 8,730 $ 163,522,921 $ (142,338,005) $ 253,734 $ (5,281,180) $ 16,169,475
Conversion of notes, shares issued   125,397          
Conversion of notes, value   $ 125 (125)        
Conversion of Series B preferred stock to shares of common stock, Shares (185,000) 185,000          
Conversion of Series B preferred stock to shares of common stock, Value $ (185) $ 185          
Share-based expense     1,784,129       1,784,129
Common stock awards to vendors     69,303       69,303
Warrant expense     (126,316)       (126,316)
Net loss       (3,595,132)     (3,595,132)
Ending balance, shares at Dec. 31, 2017 3,030,742 9,041,426          
Ending balance, value at Dec. 31, 2017 $ 3,090 $ 9,040 165,249,912 (145,933,137) 253,734 (5,281,180) 14,301,459
Exercise of warrants, shares   370,000          
Exercise of warrants, value   $ 370 1,479,630       1,480,000
Conversion of Series B preferred stock to shares of common stock, Shares (316,348) 316,348          
Conversion of Series B preferred stock to shares of common stock, Value $ (316) $ 316          
Share-based expense     1,351,873       1,351,873
Common stock awards to vendors     69,708       69,708
Warrant expense     10,206       10,206
Net loss       (7,300,458)     (7,300,458)
Ending balance, shares at Dec. 31, 2018 2,774,394 9,727,774          
Ending balance, value at Dec. 31, 2018 $ 2,774 $ 9,726 $ 168,161,329 $ (153,233,595) $ (253,734) $ (5,281,180) $ 9,912,788